CKS2 and neoplasm: Interestingly, patients with high CKS2 expression displayed low infiltration levels of B cells, CD8+ T cells, CD4+ T cells, NK cells, and DCs, indicating that high CKS2 expression may suppress innate immunity and adaptive immunity in the tumor microenvironment, based on the results from TCGA, TIMER and our cohort.